Drug Delivery Industry

Below are the top drug delivery stocks on the NASDAQ in terms of EPS growth forecast for the next five years. Alkermes Plc (NASDAQ: ALKS) earnings per share growth forecast for the next five years is 35.00 percent. Alkermes' trailing-twelve-month gross margin is 74.70 percent. Flamel...

Below are the top drug delivery stocks on the NASDAQ in terms of EPS growth forecast for the next five years. Alkermes Plc (NASDAQ: ALKS) earnings per share growth forecast for the next five years is 61.00 percent. Alkermes' trailing-twelve-month revenue is $649.80 million. Flamel Technologies S...

Below are the drug delivery stocks on the NASDAQ in terms of revenue. The trailing-twelve-month revenue at Alkermes plc (NASDAQ: ALKS) is $577.21 million. Alkermes' profit margin for the same period is 4.08%. The trailing-twelve-month revenue at PetMed Express (NASDAQ: PETS) is $235.88 million....

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of PEG ratio. Valeant Pharmaceuticals International (NYSE: VRX) has a PEG ratio of 1.09. Valeant's trailing-twelve-month revenue is $4.69 billion. Elan Corporation plc (NYSE: ELN) has a PEG ratio of 1.84. Elan had $1.94...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of PEG ratio. Valeant Pharmaceuticals International (NYSE: VRX) has a PEG ratio of 0.99. Valeant's trailing-twelve-month revenue is $4.03 billion. Elan Corporation plc (NYSE: ELN) has a PEG ratio of 1.61. Elan had $1.96...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of cash. Valeant Pharmaceuticals International (NYSE: VRX) had $2.54 billion in total cash and $10.79 billion in total debt for the latest quarter. Elan Corporation plc (NYSE: ELN) had $1.96 billion in total cash and no...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of PEG ratio. Valeant Pharmaceuticals International (NYSE: VRX) has a PEG ratio of 0.76. Valeant had $413.74 million in total cash for the latest quarter. Hospira (NYSE: HSP) has a PEG ratio of 2.49. Hospira's trailing-...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of PEG ratio. Alkermes plc (NASDAQ: ALKS) has a PEG ratio of 0.37. Alkermes had $209.30 million in total cash for the latest quarter. Valeant Pharmaceuticals International (NYSE: VRX) has a PEG ratio of 0.97. Valeant's...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of profit margin. The trailing-twelve-month profit margin at Elan Corporation (NYSE: ELN) is 44.98%. Elan's revenue for the same period is $200.00 thousand. The trailing-twelve-month profit margin at PetMed Express (NASDAQ...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of earnings estimate for the next quarter. Hospira (NYSE: HSP) is estimated to post earnings of $0.51 per share in the March quarter. Hospira's trailing-twelve-month revenue is $4.01 billion. PetMed Express (NASDAQ: PETS)...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at PetMed Express (NASDAQ: PETS) is 17.56%. PetMed Express' operating margin for the same period is 10.67%. The trailing-twelve-month return on assets at Elan...

Below are the top drug delivery stocks on the NYSE in terms of revenue. The trailing-twelve-month revenue at Hospira (NYSE: HSP) is $4.02 billion. Hospira had $655.90 million in total cash for the latest quarter. The trailing-twelve-month revenue at Valeant Pharmaceuticals International (NYSE:...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of return on assets. The trailing-twelve-month return on assets at PetMed Express Inc (NASDAQ: PETS) is 16.48%. PETS's revenue for the same period is $238.25 million. The trailing-twelve-month return on assets at Elan...

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of operating margin. The trailing-twelve-month operating margin at Valeant Pharmaceuticals International Inc (NYSE: VRX) is 24.98%. VRX's revenue for the same period is $2.75 billion. The trailing-twelve-month operating...

Below are the top drug delivery stocks on the NYSE in terms of cash. Hospira Inc (NYSE: HSP) had $597.50 million in total cash and $1.75 billion in total debt for the latest quarter. Elan Corporation plc (NYSE: ELN) had $272.00 million in total cash and $615.00 million in total debt for the...